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Asthma is a heterogeneous disease that affects approximately 300 million people 
worldwide, largely in developed countries. The etiology of the disease is poorly under-
stood, but is likely to involve specific innate and adaptive responses to inhaled microbial 
components that are found in allergens. Fungal-derived allergens represent a major 
contributing factor in the initiation, persistence, exacerbation, and severity of allergic 
asthma. C-type lectin like receptors, such as dectin-1, dectin-2, DC-specific intercellular 
adhesion molecule 3-grabbing nonintegrin, and mannose receptor, recognize many 
fungal-derived allergens and other structurally similar allergens derived from house dust 
mites (HDM). In some cases, the fungal derived allergens have been structurally and 
functionally identified alongside their respective receptors in both humans and mice. In 
this review, we discuss recent understanding on how selected fungal and HDM derived 
allergens as well as their known or unknown receptors shape allergic airway diseases.
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iNTRODUCTiON
Over the past few decades, it has become widely accepted that fungi can contribute negatively to 
many aspects of human health and the particular focus on this review is allergic airway diseases. 
Two-thirds of asthmatics display an atopic response to multiple allergens, with at least 6–8% of the 
world’s population suffering due to exposure to mold and other microbial components (1, 2). Fungal 
sensitization plays a role in patients with respiratory allergic disease through initiation, persistence, 
and exacerbation of allergic asthma. There is a correlation in the number of patients sensitized to fungi 
and the severity of asthma (3). The exact estimate of the prevalence of fungal sensitization among 
asthma patients is unclear, partly because exposure is universal, variable in time and intensity (4).
Asthmatics can be sensitized to multiple fungal species, and early exposure in the first 3 months 
of life has been associated with increased risk of developing asthma in children (5). The most 
common fungal species associated with sensitization, include Alternaria alternata, Penicilium spp., 
Cladosporium spp., Aspergillus spp., and C. albicans (6). Sensitization to fungi occurs everywhere, 
both indoors and outdoors, and this is linked to asthma exacerbations (7). Allergic bronchopulmo-
nary aspergillosis (ABPA) is a disease caused by bronchial colonization with Aspergillus spp. and 
it affects approximately 0.7–3.5% of asthmatics (2). The disease features closely resemble those of 
severe asthmatics sensitized to fungi and both groups of patients have significantly better outcomes 
if treated with antifungals, such as itraconazole and voriconazole (3, 8, 9). In a study conducted in 
North India, the prevalence of ABPA and fungal hypersensitivity among acute asthma patients was 
estimated at 38.6 and 50.9%, respectively, and the overlap between diseases was estimated at 75.9% 
using a skin prick test (10).
TAbLe 1 | Common allergens found in fungi and house dust mites (HDM) and their binding receptors.
Allergen Source Receptor Localization Reference
β-glucan HDM
A. fumigatus
A. versicolor
C. cladosporioides
Dectin-1 Macrophage, monocytes, subsets of DCs, epithelium, 
basophils
(108, 117, 118)
α-mannans HDM
A. fumigatus
C. neoformans
Dectin-2 Macrophage, monocytes, subsets of DCs, basophils (46, 48, 53–55)
Derp-1
Derp-2
BG-60
HDM
HDM
DC-specific intercellular adhesion molecule 
3-grabbing nonintegrin
Monocyte-derived DCs (63–65)
Derp-1
Derp-2
HDM
HDM
Cockroach
Mannose receptor DCs, macrophages (76, 77)
Derp-1
Derf-1
Glycoprotein 55 
and 45
HDM
HDM
A. fumigatus
Surfactant protein A and D Alveolar type II cells (84, 125)
Chitin HDM
A. fumigatus
Mannose receptor, dectin-1/TLR-2, NOD, 
RegIIIγ, FIBCD1
FIBCD1 (gut enterocytes), RegIIIγ (gut epithelium) (30, 33, 36, 39)
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Allergic bronchopulmonary aspergillosis is characterized by a 
Th2 cell infiltrate, increased pulmonary and blood eosinophilia, 
brownish black mucus plugs, total serum IgE levels over 1,000 ng/mL 
(416 IU/mL), Aspergillus-specific IgE and IgG1 antibodies (3). 
These characteristics are similar to allergic asthmatics sensitized 
to various allergens such as those derived from house dust mites 
(HDM), pollen, cockroach, etc. In fact many fungal sensitized 
asthmatics can be misdiagnosed as having ABPA with further 
tests usually required to rule out ABPA (2, 11). A considerable 
difference in fungal sensitized asthmatics is that they do not 
show signs of bronchial colonization by A. fumigatus and are 
immunologically sensitized to more than one fungal species, such 
as A. alternata, P. notatum, C. herbarum, A. fumigatus, A. niger, 
and C. albicans (3). Other useful methods for identifying ABPA, 
include computed tomography scan, chest radiographic lesions, 
and plasma levels of CCL17 which in combination with other 
criteria can help to stratify patients (12). This shows an overlap 
in clinical diagnosis, treatment, and fungal spores responsible 
for initiating these diseases (11). Fungal spores are diverse, and 
ubiquitous in our environment, making it difficult to estimate an 
average number of spores humans inhale per day (13, 14).
The majority of fungal spores in outdoor environments 
belong to the phylum Ascomycota and Basidiomycota (2). Most 
fungi contain multiple and variable allergens derived from 
conidia, spores, hyphae, or hyphal fragments and these are easily 
inhalable and likely to be the causal factors in allergic asthma. 
Some of these allergens are released during lysis/breakdown 
of fungal spore/hyphae and some are secreted by the fungus 
(14). Although protease allergens from fungi represent a larger 
proportion and are the most studied of the fungal allergens, 
other molecules, which are part of the fungal cell wall like chitin, 
mannans, and β-glucans, represent an important group of fungal 
allergens (Table 1). In recent years, there has been a huge effort 
in understanding what host-factors recognize fungal species and 
how the immune response to these fungal patterns is initiated 
and intricately regulated. C-type lectins were discovered as major 
fungal recognition receptors and shown to play critical roles in 
innate immunity and directing adaptive responses. The focus of 
this review is to highlight how fungal-derived allergens and their 
respective receptors (mainly, but not limited to C-type lectins) 
shape asthma.
C-TYPe LeCTiN ReCePTORS
C-type lectin-like receptors (CLRs) are carbohydrate, lipid, or 
protein binding proteins, identified by the unique structure of at 
least one C-type lectin-like domain (CTLD). The CLRs family of 
proteins is made of more than 1,000 members, organized into 17 
groups with diverse functions, including cell adhesion, phagocy-
tosis, complement activation, innate immunity, and others (15). 
CLRs recognize non-self, microbial pattern-associated molecular 
patterns (PAMPs) on surface of fungi, bacteria, viruses, parasites, 
and house dust mite allergens (16, 17). They can also recognize 
damaged self-antigens, damage-associated molecular patterns 
or tumor antigens, tumor-associated molecular patterns (16). 
CLRs mostly recognize extracellular ligands, but some have 
been reported to recognize endogenous intracellular ligands, for 
example, DNGR-1 senses F-actin (18). The recognition occurs 
through their extracellular structurally conserved CTLD and is 
tightly regulated by specific amino acid motifs, calcium ions, and 
the carbohydrate structure. Once engaged with their respective 
ligands they induce intracellular signal pathways coupled to 
spleen tyrosine kinase (Syk). Downstream, Syk phosphorylates 
a number of substrates, such as protein kinase c-delta (PKC-δ), 
which in turn phosphorylates CARD-9 resulting in the forma-
tion of a complex made up of CARD-9, Malt-1, Bcl10 (19–22). 
This leads to activation of NF-kB and induction of inflamma-
tory responses including activation of anti-microbial responses 
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and cytokine production that direct both innate and adaptive 
responses (19, 23). Some Syk coupled CLRs possess an intracel-
lular immunoreceptor tyrosine-based activation motifs (ITAM) 
on their signaling tail that acts as an adaptor which recruits and 
activates Syk (24). Other pathways that do not involve ITAMs 
have been reported to trigger Raf-1 activation via receptors 
such as DC-specific intercellular adhesion molecule 3-grabbing 
nonintegrin (DC-SIGN) and dectin-1. Some Syk coupled CLRs 
lack the intracellular signaling tail and rely on ITAM coupled 
FcRγ adaptors for engagement with Syk. CLRs can be classified 
according to their ability to interact and signal directly with Syk 
(cluster 1) or requirement for adaptor molecule FcRγ (cluster 2). 
Cluster 1 mainly consists of dectin-1-like CLRs, such as Clec-2 
and DNGR1, and the second cluster mainly consists of dectin-
2-like CLRs, such as MCL and Mincle (25). Not all CLRs are 
activating upon ligand binding and some CLRs have an integral 
immunoreceptor tyrosine-based inhibitory motif (ITIM) on their 
cytoplasmic tail, such as MICL (26).
Chitin Detecting CLRs
Chitin, a polymer of β-(1–4)-poly-N-acetyl-d-glucosamine 
repeating units is found in various organisms, including fungi, 
arthropods, helminth parasites, and mites. In fungi, chitin con-
stitutes about 2% of the fungal cell wall dry weight, and forms 
part of the cell wall inner layer giving it its rigidity (27). How 
chitin is sensed by the host immune cells remains controversial 
and unresolved (28). To date the only chitin vertebrate-specific 
receptor identified is FIBCD1, a 55  kDa homotetrameric type 
II transmembrane protein expressed in gut enterocytes (29). 
Chitin sensing has been speculated to involve engagement of 
multiple PRRs, including TLR-2, dectin-1, TLR-9, NOD recep-
tor, mannose receptor, and soluble C-type lectin RegIIIγ, in a 
polymer size, concentration, and acetylation status-dependent 
manner (30–32). Smaller chitin fragments (1–10  µm) promote 
anti-inflammatory IL-10 production in a MR-, NOD-, and TLR9-
dependent manner, whereas intermediate fragments (40–70 µm) 
promote pro-inflammatory cytokine TNF-α in a dectin-1/TLR-2 
manner both in vitro and in vivo (31, 32). Larger ones (50–100 µm) 
promote eosinophilic inflammation and alternatively activated 
macrophages in vivo (33–35). However, difficulties in purifying 
high quality chitin and mannan contaminated commercial chitin 
have left some speculations on whether contaminants could be 
partly responsible for multiple PRR engagement. Aspergillus 
fumigatus and crustacean-derived chitin was shown to initiate 
innate allergic responses by recruiting IL-4 positive immune 
cells, such as eosinophils and basophils (33, 35, 36). Chitin was 
shown to activate ILC2s by inducing IL-33, IL-25, and TSLP 
production by the epithelial cells (33). It was further shown that 
chitin induced alternative-activated macrophages (AAMs, M2) 
and eosinophilia an ILC2-dependent manner. Lack of IL-25, 
TSLP, and IL-33 resulted in normal lung ILC2 accumulation, 
but reduced secretion of IL-5 and IL-13 which lead to reduced 
AAM and eosinophilia (33). The role of chitin in Th2-mediated 
airway inflammation was also supported by another study that 
showed that chitin induced CCL2 production by epithelial cells, 
which in turn activated AAMs and eosinophilia in a CCR2-
dependent manner (37). Mice constitutively overexpressing 
acidic mammalian chitinase (AMCase) (SPAM mice) in the 
lung, when challenged with chitin or A. fumigatus had attenu-
ated eosinophilia, AAMs, and Th2-associated cytokines (33, 
35, 36, 38). In addition, AMCase enzyme dead knock-in mice 
(AMCase-ED) or AMCase knock-in/knock-out (ChiaRed) mice 
are unable to clear chitin polymers and have heightened Th2 
type and pro-fibrotic lung inflammation at steady state or when 
exposed to medium or large chitin particles, crude HDM (large 
particles chitin content) or filtered HDM (small particle chitin 
content) (38, 39). However, AMCase-deficient mice have given 
contradictory reports compared to AMCase-ED or ChiaRed 
mice (38, 39). AMCase-deficient mice did not show aberrant 
type 2 responses during ovalbumin or HDM-induced allergic 
asthma (40, 41). These contrasting findings between these mice 
remain to be reconciled by direct comparison of the strains. One 
key difference between the two strains is that AMCase-ED and 
ChiaRed mice are able to express AMCase protein which is capa-
ble of binding chitin, however, the chitinase activity is diminished 
(38, 39).
Much remains to be learnt about the mechanisms involved in 
chitin recognition and clearance. Currently, it is unclear whether 
the PRRs that have been implicated in recognition of small and 
medium sized chitin polymers to induce IL-10 and TNF-α will 
be the same receptors inducing Th2 type allergic asthma. None 
of the receptors identified so far as chitin recognition receptors 
which are specific to chitin apart from FIBCD1. FIBCD1 seems 
to be expressed specifically in the stomach and not lung tissue. 
Perhaps the role of this receptor as a chitin-specific receptor will 
become clearer once FIBCD1-deficient mice become available. 
In humans, an AMCase single nucleotide polymorphism exists 
displaying hyper chitinase activity (42). This AMCase isoform is 
common among American ethnic groups and has been associ-
ated with protection against asthma (42).
Dectin-2
Dectin-2 is a 28 kDa, type II transmembrane CTLR, containing a 
single extracellular CTLD connected by a neck region to its short 
cytoplasmic tail (43). Dectin-2 recognizes high mannose struc-
tures on the surfaces of a wide range of microbes and has also been 
shown to have a putative endogenous ligand on CD4 T cells (44, 45). 
Moreover, dectin-2 recognizes α-mannans in many species of 
fungi, including C. albicans, Paraccoides brasiliensis, Histoplasma 
capsulatum, and Cryptococcus neoformans (46, 47). Apart from 
fungal ligands, dectin-2 has also been shown to recognized HDM 
allergen (Dermatophagoides farinae and D. pteronyssinus) (48), 
although the exact nature of ligands have not been elucidated.
Dectin-2 has no obvious signaling motif on its short cytoplas-
mic tail and relies on the ITAM-bearing FcRγ chain for signal 
transduction and downstream effects, including NFkB activation, 
Syk recruitment, and cytokine production (45, 49). The FcRγ 
chain and its phosphorylation by Src kinases were shown to be 
important for the surface expression of dectin-2 and the subse-
quent downstream signals (45, 49).
In C. albicans, mice deficient in dectin-2 are susceptible to 
systemic infections and fail to mount Th17 responses critical 
for fungal clearance (45, 47, 50). In the cases of allergic asthma 
induced by D. farinae mites, dectin-2 was shown to be activated 
FigURe 1 | Schematic diagram of selected C-type lectin-like receptors (CLRs) and their respective ligands. C-type lectin receptors bind to their respective 
extracellular microbial pattern-associated molecular patterns on cell wall surfaces of fungi and house dust mites. Most CLRs signal via a Syk-dependent pathway 
inducing reactive oxygen species, inflammatory cytokines, and antimicrobial peptides. Some CLRs, e.g., dectin-1 and DC-specific intercellular adhesion molecule 
3-grabbing nonintegrin can signal via a Syk-independent pathway involving Raf-1. Some CLRs (such as dectin-2 and MR) cannot directly activate Syk, but require 
adaptor protein FcRγ attached to its intracellular immunoreceptor tyrosine-based activation motifs. Soluble CLRs, such as surfactant proteins (SP-A, SP-D) are 
arranged in either one or two polypeptide chains with a CRD connected to neck region, a collagen-rich domain, and cytoplasmic region. FD, fibronectin domain; 
CRD, carbohydrate recognition domain; COR, collagen-rich domain.
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by a yet unidentified ligand (51, 52). Dectin-2 activation during 
the sensitization stage in DCs triggers generation of cysteinyl 
leukotrienes, pro-inflammatory lipid mediators, Th2 cytokines, 
in a FcRγ-, Syk-, and CARD-9-dependent manner (51, 53). 
Blocking of dectin-2 with antibody during the HDM challenge 
stages showed a redundant role of the receptor in airway inflam-
mation and AHR (54). In contrast, antibody-mediated blockage 
of dectin-2 and dectin-2-deficient mice sensitized with wild type 
D. furinae-pulsed DCs had attenuated pulmonary inflamma-
tion (55). Moreover, dectin-2 deficiency had little effect on Th2 
cytokine production by lung-draining MLN and systemic IgE and 
IgG1 production, suggesting that dectin-2 mediates localized Th2 
responses during the effector phase (54, 55). Indeed, the mecha-
nisms of dectin-2/HDM-induced Th2 allergic airway responses 
has been shown to require FcRγ-dependent type 2 alarmin IL-33 
secretion and its autocrine signaling receptor ST2, which is thought 
to promote lung DCs maturation (56). Recently, phosphorytidyl-
inositol 3 kinase delta (PI3Kδ) signaling pathway was also shown 
to be required for the dectin-2/FcRγ-dependent cysteine leukot-
riene production and Th2 and Th17 allergic airway responses 
induced by D. furinae (57). Inhibition of PI3Kδ ameliorated 
HDM-induced allergic asthma, suggesting a targetable pathway 
in the treatment of asthma. Interestingly, PBMCs from asth-
matic patients were shown to upregulate expression of dectin-2, 
suggesting an important role for this receptor in human disease 
(54). Despite dectin-2 being shown to be important in antifungal 
immunity and in asthma in mouse models, no single mutation 
associated with disease has been observed so far in humans.
DC-Specific intercellular Adhesion 
Molecule 3-grabbing Nonintegrin
DC-specific intercellular adhesion molecule 3-grabbing nonin-
tegrin is a 44 kDa type II transmembrane protein receptor (58). 
DC-SIGN is arranged as a tetramer of autonomous CTLD that 
interact through alpha helix neck domain (59). It consists of an 
extracellular domain that contains a CRD arranged in a homodi-
meric cluster, a hinged domain followed by a transmembrane 
region and a cytoplasmic domain/signaling tail (Figure 1). The 
CRD recognizes a broad spectrum of mannose and fucose ligands 
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on various microbes, including viruses (HIV gp120 glycoprotein, 
measles viruses), parasites (Leshmania spp., S. mansoni), fungi 
(C. albicans), bacteria (Helicobacter pylori, M. tuberculosis, and 
M. leprae), and self-ligands, such as, ICAM-2, ICAM-3, and 
Mac-1 (58, 60). The carbohydrate structure recognition by CRD 
seems to be Ca2+-dependent. Because of its broad specificity to 
sugar moieties, DC-SIGN has been shown to be an exploitable 
target for many pathogens as they use it to subvert host killing 
mechanisms (58, 59).
Although DC-SIGN lacks the consensus signaling motifs 
that interact with Syk kinases and other downstream adap-
tors, DC-SIGN still acts as a signaling receptor. Activation of 
DC-SIGN does not induce an immediate downstream signal, 
however, DC-SIGN has been shown to modulate signals initiated 
by toll-like receptors (61). Depending on the engaged ligand, 
e.g., fucose or mannose, the intracellular tail of DC-SIGN forms 
a ligand-specific signalomes with kinases including Raf-1. This 
enhances phosphorylation and acetylation of NFkB subunit p65 
and heightened pro-inflammatory (Th1) or suppression of NFkB 
activation and induction of anti-inflammatory (IL-10 and Th2) 
gene transcription (61, 62).
Allergens containing protease activity have been shown to 
have multiple mechanisms of generating allergic inflamma-
tion. The major peanut allergen (Ara h 1), grass pollen allergen 
(BG-60), major dog allergen (Can f 1), and major dust mite aller-
gens (Derp-1 and Derp-2) have been shown to activate DC-SIGN, 
initiating cytokine production and allergic inflammation biased 
toward Th2 polarization (63–65).
Binding of glycosylated Derp-2 to DC-SIGN on human DCs 
elicits TNF-α release. Furthermore, in DC/T-cell co-culture 
experiments Derp-1 pre-treated monocyte-derived DC induced 
GATA3 and IL-4 expression by naive T  cells (66). This is also 
supported by studies showing that Derp-1 stimulation of human 
DCs leads to downregulation of DC-SIGN and bias toward 
Th2 polarization (63, 66). Moreover, DCs from atopic asthmat-
ics have reduced DC-SIGN expression which correlates with 
data demonstrating downregulation of DC-SIGN expression by 
Derp-1 during the differentiation of immature monocyte-derived 
DCs (66).
The mechanism for Th2 differentiation by protease/DC-SIGN 
engagement are not fully understood, but are thought to be due 
to the loss of DC-SIGN expression through cleavage. This leads 
to reduced binding to its ligand ICAM-3 on naive T cells, which 
is thought to be important in Th1 polarization (67). Although 
protease cleavage of DC-SIGN is the most studied mechanism 
for Th2 type response induction, other studies suggests that non-
proteolytic mechanisms involving selective DC-SIGN activation 
by fucose ligands may direct Th2 cell differentiation (62). Fucose 
from pathogens, such as H. pylori and soluble egg antigen, from 
S. mansoni was recently shown to directly inhibit TLR-4-induced 
pro-inflammatory cytokine production associated with Th1 
polarization and activated anti-inflammatory cytokine IL-10 
and Th2-associated chemokines CCL17 and CCL22. This fucose 
triggering of DC-SIGN required an initial TLR-4 priming, Raf-1 
activation, and displacement of the mannose signalome on the 
signaling tail of DC-SIGN. Downstream, Bcl3, an NFkB subunit 
interferes with p50–p65 subunit dimerization and binds to p65 
binding site and translocate to the nucleus, thereby repressing 
NFkB-dependent transcription of pro-inflammatory genes (62). 
Whether this fucose/DC-SIGN signaling and Th2 differentiation 
is a common mechanism for all fucose decorated allergens such as 
those derived from fungi or HDM, and how DC-SIGN selectively 
engages different carbohydrate, is currently unclear and requires 
further investigation.
Studies on DC-SIGN function in vivo are limited as there are 
no murine orthologs, although several murine homologs, such 
as SIGNR3 and SIGNR5, exist with gene-deficient mice available 
(59). However, the marked differences in signaling pathways 
downstream of DC-SIGN and its supposed murine orthologs 
puts into question their validity in experimental models.
Mannose Receptor
Mannose Receptor was one of the first CLR to be discovered and 
was shown to be involved in the clearance of glycoproteins (68, 69). 
Mannose receptor is a 175 kDa type I integral transmembrane 
glycoprotein that binds structures like l-fucose, d-mannose, 
or N-acetylglucosamine through Ca2+-dependent mechanisms 
as well as structures, such as sulfated acidic glycans through 
the cysteine-rich domain (70). Like DC-SIGN, MR structure 
has 3 regions, a cysteine-rich domain, a fibronectin type II-like 
domain, and 8 CTLDs, followed by a transmembrane region and 
a hydrophilic internal cytoplasmic domain (Figure 1) (68, 70). 
The cytoplasmic domain participates in receptor internalization 
and recycling, whereas the fibronectin type II-like domain medi-
ates collagen binding (68).
Mannose receptor has been shown to recognize a range of 
organisms, including C. albicans (71), P. carinni (72), HIV (gp120) 
(73), mycobacterium (74), Leishmania, and some bacterial spe-
cies. MR has also been shown to bind endogenous self-antigens, 
including ligands in the B cell follicles in the spleen and thyroid 
(68, 75).
Although MR was one of the first studied CLR, its signaling 
pathways have been a matter of considerable interest, mainly 
because the cytoplasmic tail lacks an ITAM or ITIM motifs. The 
tyrosine residue on the 18th position of the MR cytoplasmic tail 
is thought to be important for receptor endocytosis (68). A recent 
study has identified the ITAM-bearing FcRγ as a key adaptor 
in human MR signaling (74). Upon ligand, mannose capped 
lipoarabinomannan (ManLAM) engagement, MR cytoplasmic 
tail interacts with FcRγ which when phosphorylated recruits 
another adaptor Grb2. Gbr2 recognizes specific motif (YxNx) 
on MR cytoplasmic tail and activates another complex Rac-1, 
Cdc42, and PAK-1. The formation of this complex eventually 
promotes phagocytosis. Once in the phagosome, Grb2 complex 
recruits a tyrosine phosphatase SHP-1 which upon phosphoryla-
tion interacts directly with Grb2 complex. SHP-1 interrupts the 
formation of MR-dependent phagosome–lysosome fusion upon 
M. tb infection and promotes M. tb growth inside phagosomes.
Similar to DC-SIGN, MR binds to a number of carbohydrate 
microbial cell surface ligands, such as mannans and proteolytic 
allergens, including HDM allergens (Derp-1 and Derp-2), 
German cockroach allergen (Bla g 2), major dog allergen (Can 
f 1), cat allergen (Fel d 1), and major peanut allergen (Ara h 1) 
(76–78). DCs from atopic asthmatics have elevated MR expression 
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and are efficient in uptake of Derp-1 HDM allergen compared to 
non-asthmatic controls (78). Furthermore, human MR-deficient 
DCs fail to induce a Th2 polarization in naive T  cell/DC co-
culture when stimulated with Derp-1. Unlike DC-SIGN, MR 
activation by protease does not involve cleavage of the receptor, 
however, it is thought to involve direct recognition by the CTLD-
4–7 region (76, 77). This is further supported by studies dem-
onstrating that human MR engagement with its ligand, Derp-1 
initiates Th2 polarization through modulation of indoleamine 
2,3-dioxygenase (IDO) activity, an immune modulator enzyme 
involved in tryptophan metabolism. In a mouse model using a 
cockroach allergen-induced allergic airway response, MR was 
shown to be important in allergen uptake and in regulation of Th2 
allergic airway inflammation, as mice deficient of MR showed 
aberrant Th2 responses (79). Mechanistically, MR together with 
its intronic microRNA (miR-55-3p) was shown to regulate mac-
rophage polarization from M2 to M1 upon cockroach allergen 
stimulation, resulting in protection against allergen-induced 
allergic airway inflammation in  vivo (79). Currently, most of 
what we know about MR in allergic asthma has been done using 
human cells and knockdown approaches. Very little been done 
in vivo using known fungal derived ligands despite the fact that 
MR-deficient mice have been available for some time and can be 
a useful resource in understanding mechanisms of MR-mediated 
asthma (79). It is also important to note that there are consider-
able differences between mouse and human MR signaling, for 
example, SHP-1 is not robustly expressed in mice and does not 
interact with MR. Humanized mice expressing a human version 
of MR will bring into light some of the key regulatory roles of MR 
in allergic asthma.
Surfactant Proteins A and D
Lung surfactant proteins A and D (SP-A and SP-D) are soluble 
PRRs secreted mainly by alveolar type II cells (pneumocytes) and 
by other cells types, including non-ciliated bronchiolar cells, lung 
epithelial cells, and gastrointestinal and genitourinary tracts (80) 
SP-A and SP-D are part of the six human collectins described 
so far (80). They recognize sugar moiety patterns on the surface 
of various pathogens, including bacteria, fungi, and viruses with 
varying preference, i.e., SP-A preferentially binds monosaccha-
rides, in contrast SP-D binds avidly to more complex saccharides 
(80). The structure of SP-A and SP-D is organized into four 
regions: an N-terminal region (which forms interchain disulfide 
bonds), a collagen-rich region containing (Gly-Xaa-Yaa) repeats, 
a neck peptide and a C-terminal CRD (which interacts with 
carbohydrate structures) (80). SP-A has two 35 kDa polypeptide 
chains (SP-A 1 and 2) arranged in a 635 kDa hexamer, SP-D has 
one 43 kDa polypeptide chain arranged in a tetramer of 520 kDa 
(Figure 1) (80, 81).
SP-A and SP-D have been shown to bind to HDM allergen 
Derp-1 and glycoprotein allergens from A. fumigatus in a 
carbohydrate-specific and Ca2+-dependent manner (82, 83). This 
was shown to inhibit IgE binding to these glycoproteins, block-
ing allergen-induced histamine release from basophils and mast 
cells, and effectively reducing IgE hypersensitivity and allergic 
inflammation (84–86). SP-A and SP-D-deficient mice are inher-
ently hypersensitive to pulmonary infections, showing increased 
eosinophilia and IL-13, a Th2-associated cytokine (86). The ability 
of SP-A and SP-D to block allergen-specific IgE and IgG1 can be 
explained by their potential to block B cell proliferation resulting 
in reduced antibody production. Another suggested mechanism 
is through production of IFN-γ by CD4 T cells, which shifts cel-
lular responses from Th2 to Th1 responses (84, 85). SP-A was 
recently shown to play an important role in local lung macrophage 
proliferation by boosting IL-4Rα signaling, which was important 
for helminth expulsion (87). It is likely that similar mechanisms 
would exist for the induction of allergic asthma, but remain to be 
investigated. Genome-wide association studies have also linked 
single nucleotide polymorphisms in SP-A1 and SP-A2 gene to 
high susceptibility to ABPA, suggesting a key role of surfactants 
in fungal-induced asthma (88).
Dectin-1
Dectin-1 is a 28  kDa type II membrane protein with a single 
extracellular lectin-like carbohydrate recognition domain con-
nected by a stalk to the transmembrane region followed by a 
cytoplasmic signaling tail (Figure 1) (89). Dectin-1 was identified 
to be a major β-(1,3)-d-glucan receptor in the early 2,000 through 
screening of mouse macrophage cDNA expression library with 
zymosan (a β-glucan-rich particle) (90). Other receptors have 
also been shown to bind β-(1,3)-d-glucan, including CR3, 
SCARF, lactosylceramide, CD36, and ephrin type-A receptor 2 
(EphA2) (91, 92). β-(1,3)-d-glucan is a glucose polymer that is 
widely distributed across the biosphere predominantly found on 
the cell wall surfaces of plants (93) and fungi (such as Candida 
spp., Aspergillus spp., Coccidiodes spp., and Pneumocystis spp.) 
(90, 94–96). Dectin-1 has also been shown to bind an unidenti-
fied endogenous ligand in T cells (89).
Upon engagement with β-(1,3)-d-glucan, dectin-1 initiates 
intracellular signals via its cytoplasmic ITAM-like motif through 
phosphorylation of a tyrosine residue residing within the 
YxxxL motif. Phosphorylation of the membrane proximal single 
tyrosine-based motif is sufficient to induce activation and recruit-
ment of Syk and this type of sequence has been termed ITAM-like 
motif or HemITAM (19, 24, 25). The hemITAM is thought to 
be important in dimerization of dectin-1 and the formation of a 
docking site for SH2 domains of Syk. Downstrean effects after Syk 
activation and recruitment are discussed above.
The wide distribution of β-(1,3)-d-glucans in nature and its 
importance in cell wall formation has brought considerable inter-
ests in its structure as a possible target for drug development or 
therapeutic potential. The β-(1,3)-d-glucan glucose polymer has 
variable molecular weight and degree of branching that can be 
triple helix, single helix, or random coil structured (97). In fungal 
cell wall, glucans compose about 40–50% of cell wall dry weight 
with at least 65–90% of the cell wall being β-(1,3)-d-glucans (98). 
β-(1,3)-d-glucans are covalently linked to β-(1,6)-glucans and 
chitin [β-(1,4)-linked polymer of N-acetylglucosamine] (98, 99). 
β-(1,3)-d-glucan serves as a backbone structure to which other 
structures are covalently bound such as N- and O-linked oligo-
saccharides, GPI anchored glycoproteins, and β-(1,6)-glucans 
forming a mesh of β-(1,3)-d-glucans sandwiched between inner 
chitin layer and outer mannan layer (27, 98). β-(1,3)-d-glucans 
(hereon referred to as β-glucans) have been shown to have 
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immunomodulatory activities, for instance anti-tumor effects 
by promoting leukocyte cytotoxic activities and hematopoiesis 
recovery after chemotherapy, protective effects against bacterial 
infections and wound healing (100). However, β-glucans have 
also been shown to have negative effects, including inducing 
formation of granulomas, triggering arthritis (101), and are 
implicated in airway inflammatory responses in human and 
animal models (102).
In humans, exposure to β-glucans has been associated with 
reduced FEV1/pulmonary function (103), however, the same 
group found no or even opposite association in later studies (104). 
Epidemiological studies evaluating multiple parameters, includ-
ing atopy, lung function FEV1, skin symptoms, inflammation, and 
cytokines, generally found very few significant associations with 
exposure to β-glucan which confirms inconsistency in the results 
(105). Subjects with previous history of airway reactivity showed 
minor nose and throat irritation, but no effects on FEV1 or air-
way responsiveness when challenged with aerosolized β-glucan 
(curdlan) (104, 106). In healthy volunteers, inhalation of low 
doses of soluble β-glucan (grifolan) showed decrease in TNF-α 
from PBMCs, but no effects on several markers of inflammation 
and pulmonary function (104). Human dectin-1 activation can 
enhance or inhibit Th2 polarization depending on the antigen 
presenting cell encountering β-glucan in  vitro (107). A recent 
study reported that stimulation of plasmacytoid DCs promote Th2 
polarization of naive T cells in vitro in a dectin-1-dependent man-
ner, whereas stimulation of monocyte-derived DCs suppressed 
Th2 polarization and favored Th17 responses in vitro (107). Other 
studies have also supported the role of dectin-1 promoting Th2 
polarization of naive T cells in vitro, by showing that β-glucans 
derived from HDM promoted secretion of Th2 type cytokines 
IL-4 and IL-13 by human DCs and CCL20 production by human 
bronchial epithelial cells, a chemokine associated with Th2 type 
immune response (64, 108, 109).
In animal models, β-glucans purified from various sources 
have been shown to contribute to allergic airway inflammation, 
mainly acting as adjuvants when topically co-administered 
with allergens (102, 110–114). A recent study showed that par-
ticulate β-glucans acted as mucosal adjuvants to HDM allergen 
when co-administered during priming phase and promoted a 
strong Th2 allergic airway response to HDM allergen (112). 
This is consistent with other studies that have shown adjuvant 
potential of β-glucans (derived from barley and baker’s yeast 
and C. albicans) when co-administered with ovalbumin (OVA), 
promoting OVA-specific IgE, eosinophilia, and Th2 cytokines 
(110, 115). In these studies, dectin-1 either had no role in the 
adjuvant effects of β-glucans to HDM/OVA allergens or was not 
investigated (110, 112, 115). Dectin-1 has also been shown to 
regulate allergic asthma induced by fungal species depending on 
the surface exposure of β-glucans. In A. versicolor live conidia-
induced asthma, dectin-1-deficient mice showed increased Th2 
type allergic airway inflammation with increased IL-33, airway 
hyperresponsiveness, and reduced IL-17A (116). In the same 
study, C. cladosporioides live conidia-induced Th2 type, eosino-
philic airway inflammation in a dectin-1-independent manner. 
Subsequent studies showed that the difference in β-glucan 
surface exposure between A. versicolor and C. cladosporioides 
was key in the distinct allergic airway profile and that dectin-1 
suppressed this Th2 type allergic asthma by promoting IL-17A 
and IL-22 type immune responses (116, 117). In A. fumigatus 
live conidia allergic asthma chronic model, dectin-1 was shown 
to promote IL-22 and immunopathology, corroborating other 
findings showing a detrimental role of dectin-1 in fungal-
induced allergic asthma (118). This type of allergic asthma is 
often seen in allergic models with neutrophilic inflammation 
that is usually unresponsive to high doses of corticosteroids 
(111, 119).
Some studies using HDM extracts to induce allergic asthma 
in animal models show requirement for dectin-1 signaling in Th2 
type, eosinophilic, allergic airway asthma (109, 120). Dectin-1 is 
mainly expressed by CD11b DCs and recognizes HDM-derived 
β-glucan-like substance to initiate a Th2 polarization and migra-
tion of lung DCs to MLN by secretion of chemokines, such as 
CCL3 and CCR7 (120). Mechanistically, during HDM-induced 
allergic asthma, dectin-1 induces the production of prostaglan-
din E2 (PGE2), which promotes M2 macrophage polarization 
and subsequently, Th2 type allergic asthma (121). It is difficult 
to reconcile studies using HDM extracts, co-administration of 
β-glucans with allergens and those using fungal species. The 
main challenge with commercial HDM extracts is that it is 
still unclear if β-glucans are contaminants derived from inges-
tion of fungi by mites or endosymbionts-derived molecules. 
Furthermore, commercial HDM extracts do vary largely in their 
content of these microbial PAMPs from batch to batch depend-
ing on preparation (122).
There are considerable inconsistencies in the results using 
β-glucans in both human and animal models as discussed 
above. The disparities could be due to the fact that differences 
in β-glucan source, content, solubility, conformation, choice, 
and strain of animal used, and whether human volunteers had 
previous fungal exposure, as discussed above. Possible clarifica-
tion for such inconsistencies using β-glucan stems from a study, 
where it was shown that dectin-1 activation requires receptor 
clustering forming a “phagocytic synapse” (123). In this study, it 
was demonstrated that larger particulate β-glucans particles had 
greater ability to induce this dectin-1 phagocytic synapse (123). 
It is now easier to explain why β-glucan exposure has resulted 
in different phenotypes. Future studies on the effects of β-glucan 
in asthma or any other immunomodulatory activities should 
certainly consider the particulate size of β-glucan to induce the 
dectin-1 phagocytic synapse. In summary, it is clear from both 
animal and mouse studies that much needs to be reconciled on 
the role of dectin-1 and its ligand β-glucans in allergic asthma. 
Already a few SNPs have been identified in human dectin-1 gene 
(CLEC7A) which correlates with development of allergic asthma, 
highlighting the importance of this receptor in driving allergic 
asthma (124).
CONCLUDiNg ReMARKS
It is becoming clear that fungal sensitization and fungal-associated 
components play a crucial role in the initiation, exacerbation, 
and severity of asthma. Evidence is now emerging showing 
that CLRs that recognize most fungal-derived components 
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are also crucial in shaping the development of allergic asthma. 
Many other fungal species, such as A. alternate, associated with 
allergic asthma have not been investigated in CLRs-deficient 
animals and the ligands and mechanisms of action remain 
elusive. Of significant interest is how some of these CLRs can 
be targeted as mucosal adjuvants in cases, where they play pro-
tective roles in asthma and drug targets, where they promote 
allergic asthma, especially difficult to treat asthma. The fact 
that CLRs can also collaborate with each other or other PRRs 
is likely to have huge implications in deciphering an already 
heterogeneous and complex disease like asthma. There is still a 
lot to be learnt about these interactions and how such collabo-
rations can be used to harness a beneficial immune response 
toward pathogens or treatment strategies for asthma. Although 
there is correlation between human and mouse data, there is 
still a considerable discrepancy in findings using CLR-deficient 
mice in allergic asthma models and in vitro data using human 
cells. CLRs-deficient animals are a useful tool in understanding 
disease mechanisms and this requires improvements to better 
mimic human asthma. Technologies like humanized mice or 
mice expressing human version of CLRs will give insights into 
how CLRs shape allergic asthma. Finally, it is clear that some 
ligands still have ambiguous or unidentified CLRs despite being 
known for generations to play key roles in allergic asthma, and 
much work remains to generate new mouse tools to decipher 
these mysteries.
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